Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
3.550
-0.160 (-4.31%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Genprex Market Cap
Genprex has a market cap or net worth of $2.91 million as of September 2, 2026. Its market cap has decreased by -47.09% in one year.
Market Cap
2.91M
Enterprise Value
-12.24M
1-Year Change
-47.09%
Ranking
Category
Stock Price
$3.55
ChartMarket Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.40M to $2.91M, a decrease of -74.47%. That is a compound annual growth rate of -14.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.91M | -27.25% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.00% |
| Dec 31, 2021 | 62.70M | -61.84% |
| Dec 31, 2020 | 164.30M | 3,121.57% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 45.61% |
| Mar 29, 2018 | 11.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 3.62M |
| Galmed Pharmaceuticals | 3.44M |
| Calidi Biotherapeutics | 3.42M |
| Jupiter Neurosciences | 3.22M |
| Curis | 3.11M |
| Propanc Biopharma | 3.08M |
| Artelo Biosciences | 3.05M |
| Matinas BioPharma Holdings | 2.94M |